Tag: NTI drugs
Prescriber Attitudes Toward NTI Drugs and Substitution
Prescribers remain cautious about substituting generic versions of narrow therapeutic index (NTI) drugs due to safety concerns, despite FDA assurances. Real-world data, state laws, and clinical experience shape ongoing debates over substitution practices.
Antiseizure Medications and Generic Substitution: Risks and Best Practices
Generic antiseizure medications can save money, but for narrow therapeutic index drugs like lamotrigine and carbamazepine, even small changes in absorption can trigger seizures. Learn the risks, who’s most vulnerable, and how to protect yourself.